AstraZeneca Holds Preliminary Talks with Bristol Myers Squibb on Potential $400 Billion Merger
Aug 04, 2026
View online
AstraZeneca Holds Preliminary Talks with Bristol Myers Squibb on Potential $400 Billion Merger
Volker Arndt: The ‘EORTC QLQ-SURV100’ Questionnaire is Now Available in 21 Languages
One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer
Fabrice Barlesi Reappointed as Director General of Gustave Roussy
Miriam Mutebi։ Strengthening Cancer Research Investment Across Africa
Highlights from BCANTT26 Shared by Petros Grivas
Adjuvant Therapy in Renal Cell Carcinoma: Who Benefits and Who Is Overtreated
LeukO 2026: Global Virtual Congress on Leukemias
FY26 Lung Cancer Research Program Idea Development Award
FY26 Lung Cancer Patient-Centered Outcomes and Survivorship Award
2026 Hereditary Cancer Genetics: Incorporation into Clinical Care
Louisiana Oncology Society 2026 Cancer Congress
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
